An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
10.1021/acsbiomaterials.2c00202
Saved in:
Main Authors: | Chua, Koon Jiew, Ling, Hua, Hwang, In Young, Lee, Hui Ling, March, John C, Lee, Yung Seng, Chang, Matthew Wook |
---|---|
其他作者: | PAEDIATRICS |
格式: | Article |
語言: | English |
出版: |
AMER CHEMICAL SOC
2023
|
主題: | |
在線閱讀: | https://scholarbank.nus.edu.sg/handle/10635/239198 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Development of probiotic nanovesicles for oral delivery in inflammatory bowel disease (IBD) treatment
由: Lin, Xiang
出版: (2024) -
MODELING GASTROINTESTINAL MOTILITY DISORDERS AND INFLAMMATION IN AN INTESTINE MICROPHYSIOLOGICAL SYSTEM
由: JANANI SICKHAN PONNAMBALAM
出版: (2024) -
DUSP4 REGULATES INTESTINAL INFLAMMATION AND TUMORIGENESIS
由: LU YI
出版: (2020) -
SOCIAL CONSTRAINTS AND LIVED EXPERIENCES IN SCHOOL: AN EXPLORATORY STUDY ON ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE IN SINGAPORE
由: DARRYL WONG WAI BIN
出版: (2020) -
Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia
由: Ong, F., et al.
出版: (2022)